glp-1 options for type 2 diabetes and obesity 2025 Many adults stop therapy within a year with low restart rates, analysis finds Comparing Ozempic, Wegovy and Other

Headaches and dizziness Headaches affect a meaningful percentage of users on both medications

If I were to stop them, the water would overflow again

It took about a year to assemble the funding for a one-year pilot program, identify a pharmacy to compound the semaglutide the active ingredient in some of the more costly, name-brand GLP-1s and find a doctor willing to prescribe the drug for off-label use to uninsured participants

Kantarjian HM, et al

As a result, different classes of molecules have been developed that are capable of interfering with the formation of the MDM2/p53 complexes (such as Nutlin) [57,58,59]